Evidence map›Paper›PMID 40443706›Full record

ArticleTobacco prevention & cessation2025

Recommendations for updating regulations on advertising, promotion and sponsorship of tobacco and nicotine products in the European Union.

Helena Koprivnikar, Dolors Carnicer-Pont, Anna M López, Adrián González-Marrón, Gunnar Sæbø, Silvano Gallus, Irene Possenti, Angeliki Lambrou, Efstathios Papachristou, Melinda Pénzes and 3 more

Abstract read
In one paragraph

Article in Tobacco prevention & cessation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Helena KoprivnikarNational Institute of Public Health, Ljubljana, Slovenia.
Dolors Carnicer-PontInstitut Catala d'Oncologia, ICO, Hospitalet de Llobregat, Barcelona, Spain.
Anna M LópezInstitut Catala d'Oncologia, ICO, Hospitalet de Llobregat, Barcelona, Spain.
Adrián González-MarrónGroup of Evaluation of Health Determinants and Health Policies, Department of Basic Sciences, Universitat Internacional de Catalunya, Sant Cugat del Valles, Spain.
Gunnar SæbøΝorwegian Institute of Public Health, Oslo, Norway.
Silvano GallusDepartment of Medical Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Irene PossentiDepartment of Medical Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Angeliki LambrouDirectorate of Epidemiology and Prevention of Non-Communicable Diseases & Injuries, National Public Health Organization (NPHO), Athens, Greece.
Efstathios PapachristouDirectorate of Epidemiology and Prevention of Non-Communicable Diseases & Injuries, National Public Health Organization (NPHO), Athens, Greece.
Melinda PénzesHealth Services Management Training Centre, Semmelweis University, Budapest, Hungary.
Sotiria SchoretsanitiDirectorate of Epidemiology and Prevention of Non-Communicable Diseases & Injuries, National Public Health Organization (NPHO), Athens, Greece.
Naia ArtetaSociedad Vasconavarra para la Prevencion del Tabaquismo, Bilbao, Spain.
Esteve FernándezInstitut Catala d'Oncologia, ICO, Hospitalet de Llobregat, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionComprehensive bans on advertising, promotion and sponsorship of tobacco and nicotine products (TAPS) have proven effective in reducing their use. The Joint Action on Tobacco Control 2 (JATC2) aims to identify TAPS gaps in the current European Union (EU) regulations and to provide comprehensive recommendations for updating them.

methodsAn online consultation with European TAPS national experts was conducted in 2023. Seventy-seven experts from 27 European countries were contacted and 38 experts from 21 countries participated in the consultation.

resultsSignificant gaps in current TAPS regulations were identified, particularly in entertainment, online media and points of sale. Citizens are not adequately protected from TAPS, the tobacco industry extensively uses loopholes to circumvent regulations. TAPS-related issues currently affect tobacco and particularly non-therapeutic nicotine products, devices, accessories, products imitations and all marketing channels, entertainment, online media and especially, social networks. To address these challenges, regulations should include bans on internet sales and TAPS at points of sale, licensing, decreased retail availability, plain packaging and ban on corporate social responsibility actions, corporate promotion and 'brand stretching'. These measures should be accompanied by effective monitoring and enforcement, dissuasive sanctions, formalized collaboration among countries and international collaboration, civil society involvement, strong public education, and community awareness programs.

conclusionsThere is an urgent need to address the current gaps in the EU TAPS regulations through comprehensive and harmonized TAPS bans across all EU countries. Updated regulations must anticipate emerging industry strategies and new products, ensuring continuous adaptation to counteract them effectively.

Indexed as

advertisinglaw enforcementlegislationnicotinetobacco

Identifiers

PMID40443706
PMCPMC12118587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.